Zivo Bioscience, Inc. (ZIVO) › Cash & EquivalentsZivo Bioscience, Inc. (ZIVO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $02010: $15.6K2011: $225.7K2012: $47.1K2013: $493.1K2014: $1.4K2015: $16.6K2016: $507.0K2017: $317.1K2018: $388.9K2019: $346.1K2020: $137.9K2021: $8.90M2022: $1.80M$1.80M2009Cash & Equivalents (USD)2022Fiscal YearCash & EquivalentsChange YoY2022$1.80M-79.8%2021$8.90M+6357.1%2020$137.9K-60.2%2019$346.1K-11.0%2018$388.9K+22.6%2017$317.1K-37.4%2016$507.0K+2956.2%2015$16.6K+1099.5%2014$1.4K-99.7%2013$493.1K+945.9%2012$47.1K-79.1%2011$225.7K+1346.5%2010$15.6K—2009$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share